Dean Schorno
Director of Finance/CFO at RIGEL PHARMACEUTICALS, INC.
Net worth: 443 180 $ as of 2024-04-29
Dean Schorno active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Director of Finance/CFO | 2018-05-28 | - |
Career history of Dean Schorno
Former positions of Dean Schorno
| Companies | Position | Start | End |
|---|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Chief Operating Officer | 2015-08-16 | 2018-04-30 |
| Director of Finance/CFO | 2015-08-16 | 2018-04-30 | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director of Finance/CFO | 2014-06-23 | 2015-08-09 |
| GENOMIC HEALTH, INC. | Director of Finance/CFO | 2011-01-09 | 2014-06-30 |
| Investor Relations Contact | 2003-06-30 | 2014-06-30 | |
| Public Communications Contact | 2003-06-30 | 2014-06-30 | |
| Corporate Officer/Principal | 2010-01-31 | 2011-01-09 |
Training of Dean Schorno
| University of California, Berkeley | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Statistics
International
| United States | 7 |
Operational
| Director of Finance/CFO | 4 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Stock Market
- Insiders
- Dean Schorno
- Experience